Detalles de la búsqueda
1.
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
Br J Haematol
; 198(1): 93-102, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383886
2.
The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma.
Eur J Haematol
; 106(5): 673-681, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539037
3.
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
Eur J Haematol
; 107(4): 416-427, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34129703
4.
The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership.
Br J Haematol
; 196(5): e52-e54, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741302
5.
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
Lancet Oncol
; 17(8): e328-e346, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511158
6.
The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database.
Haematologica
; 106(6): 1733-1736, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054120
7.
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 21(12): 2039-2051, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428082
8.
Working after cancer: psychological flexibility and the quality of working life.
J Cancer Surviv
; 18(1): 196-206, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36964294
9.
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database.
EJHaem
; 5(3): 474-484, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38895063
10.
Cancer, now what? A cross-sectional study examining physical symptoms, subjective well-being, and psychological flexibility.
Health Psychol Behav Med
; 11(1): 2266220, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37849745
11.
How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnership.
Res Involv Engagem
; 9(1): 60, 2023 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516883
12.
Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.
Cancer Med
; 12(4): 4357-4362, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161712
13.
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Blood Cancer J
; 13(1): 111, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474492
14.
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
Blood Cancer J
; 13(1): 137, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37669949
15.
Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort Study.
JACC CardioOncol
; 4(1): 85-94, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35492824
16.
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.
Blood Cancer J
; 12(6): 98, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768410
17.
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
Front Oncol
; 12: 826342, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251992
18.
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.
Curr Oncol
; 29(3): 1575-1582, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323332
19.
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma.
Mol Ther Oncolytics
; 24: 695-706, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35284625
20.
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database.
Clin Lymphoma Myeloma Leuk
; 22(8): 608-617, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379589